```text
Wiki Article
Tesidolumab (LFG316, 1531594-08-7): A Research Tool for Immunological Studies
Tesidolumab, labeled as LFG316, specified by the CAS number 1531594-08-7, functions as a critical investigational instrument for furthering immunological studies. The antibody largely interacts with particular target linked to immune mediated processes, making it to be used applied to examine the nature of immune regulation. Researchers utilize Tesidolumab to gain insights into pathology occurrence and to uncover potential treatment strategies. The availability as an substance allows extensive assessment within laboratory and in vivo models.
```
```text
Investigating Tesidolumab (LFG316) in Research Applications
Investigators are progressively exploring the research application of tesidolumab (LFG316) in a variety of scientific studies. Preliminary findings suggest this compound could provide crucial insights into biological processes related to allergic disorders. Specifically, current investigations center on assessing its effect on lymphocyte response and molecule secretion, with the objective of elucidating innovative therapeutic targets and possibly improving next-generation treatment approaches .
```
Tesidolumab LFG316: Examining Potential Study Directions
Additional study into the drug LFG316 offers compelling possibilities for ongoing analysis. Key areas of focus could encompass:
- Analyzing its efficacy in various patient groups, particularly those experiencing intense inflammatory conditions.
- Establishing the precise mode of action and its impact on bodily functions.
- Investigating potential biomarkers that forecast therapeutic outcome and permit for individualized treatment.
- Evaluating the extended well-being history and detecting any anticipated negative reactions.
Research Grade Tesidolumab (1531594-08-7) – Specifications and Applications
Tesidolumab, identified by the CAS number 1531594-08-7, is a laboratory grade antibody currently under investigation for its clinical utility in inflammatory conditions . High purity is maintained through rigorous quality assurance processes, resulting in a product typically presenting a purity of ≥95% as assessed by SEC . Typical presentations are available as a sterile, lyophilized powder, requiring reconstitution with a appropriate buffer. click here Potential applications for this therapeutic include, but are not limited to, preclinical studies concerning inflammatory pathways. Further information regarding specific details can be found through the technical documentation .
- MW : Approximately 145 kDa
- Storage Conditions : -20°C or below
- Reconstitution : PBS
LFG316 for Investigation : Procurement and Administration
Accessing Tesidolumab for research requires careful evaluation and adherence to strict procedures. Currently, Tesidolumab is generally available through specialized biological resource centers , often under a limited supply program. Obtaining typically involves a detailed request process describing the intended study design. Administering this molecule demands expertise; it's usually delivered in a frozen form requiring specialized equipment for thawing and maintenance.
- Strict temperature maintenance is imperative.
- Suitable personal lab attire must be worn.
- Byproduct removal should follow accepted institutional policies .
```text
Unlocking Understanding with the Compound: A Scientific Substance (1531594-08-7)
Analysts employing Tesidolumab (1531594-08-7), a valuable scientific reagent, have started to reveal important understanding into challenging immunological processes. This compound delivers a distinct chance for investigating disorder pathways and promising therapeutic goals. More experiments requiring Tesidolumab indicate to produce important progress in the domain of disease research.
```
Report this wiki page